ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links0 made here, not in the record13 judgments2 judges (our rules as one)0 record changes seen
Model not recordedOur rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05116189Pembrolizumab/Placebo PlusPaclitaxel With or WithoutBevacizumab forPlatinum-resistantRecurrent Ovarian Cancer(MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).Merck Sharp & Dohme LLCPhase 3 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Wider: a narrower term is filedWider: a narrower term is filedCarcinoma, Ovarian Epitheli…The registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionFallopian Tube NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termParkinson Disease 4, Autoso…The registry's MeSH filing›Nov 14 · Our condition-kind rule · MisfiledMisfiledDRUGSPembrolizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Our role rule · TestedTestedPaclitaxelIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundBevacizumabIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundDocetaxelIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Pembrolizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 1PaclitaxelA model not recordedBackgroundCurrent
Nov 1BevacizumabA model not recordedBackgroundCurrent
Nov 1DocetaxelA model not recordedBackgroundCurrent
Nov 14Ovarian NeoplasmsOur condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Carcinoma, Ovarian EpithelialOur condition-kind ruleFinest filed termCurrent
Nov 14Fallopian Tube NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Parkinson Disease 4, Autosomal Dominant Lewy BodyOur condition-kind ruleMisfiledCurrent
Nov 18PembrolizumabOur role ruleTestedAgrees
Nov 18PaclitaxelOur role ruleBackgroundAgrees
Nov 18BevacizumabOur role ruleBackgroundAgrees
Nov 18DocetaxelOur role ruleBackgroundAgrees
As of nowCarcinoma, Ovarian EpithelialOur main-condition rule (R9)Main conditionCurrent